New Zealand markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
250.35-9.57 (-3.68%)
At close: 04:00PM EST
250.35 +0.04 (+0.02%)
After hours: 04:07PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
3,781,267
3,540,160
2,923,933
2,621,226
Cost of revenue
2,370,388
2,205,522
1,850,392
1,662,915
Gross profit
1,410,879
1,334,638
1,073,541
958,311
Operating expenses
Selling general and administrative
609,570
619,919
528,935
517,622
Total operating expenses
750,907
744,776
640,812
607,160
Operating income or loss
659,972
589,862
432,729
351,151
Interest expense
36,058
73,910
86,433
60,882
Total other income/expenses net
-82,952
-35,894
99,984
12,293
Income before tax
541,708
480,710
447,114
304,084
Income tax expense
98,379
81,873
81,808
50,023
Income from continuing operations
443,329
398,837
365,306
254,061
Net income
436,394
390,982
364,304
252,019
Net income available to common shareholders
436,394
390,982
364,304
252,019
Basic EPS
-
7.77
7.35
5.17
Diluted EPS
-
7.60
7.20
5.07
Basic average shares
-
50,293
49,550
48,730
Diluted average shares
-
51,425
50,611
49,693
EBITDA
-
820,160
768,471
563,061